Meds A-Z
Oxytetracycline
Detailed information about Oxytetracycline
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati , and E. maxima ; and for the control of complicated chronic respiratory disease (CRD or air-sac in...
What it does:
It is used in dogs for the treatment of bacterial pneumonia caused by Brucella bronchiseptica, tonsillitis caused by Streptococcus hemolyticus, bacterial enteritis caused by Escherichia coli, urinary tract infections cau...
When it's needed:
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drink...
Call your vet sooner if you notice:
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero-day slaughter withdrawal in swine.
Commonly reported reactions:
- (2 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Oxytetracycline
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Phibro Animal Health Corp.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/99006 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/138939 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero-day slaughter withdrawal in swine.
- High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero-day slaughter withdrawal in swine.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 |
Species coverage: Cat (20) Dog (12)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2023-US-021175
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 167 • Secondary summaries: 0
- Coban™/TM® · SPL
- Neo-Oxy 50/50® · SPL
- Neo-Oxy 100/100 MR® · SPL
- Neo-Terramycin® 100/100 · SPL
- Neo-Terramycin® 50/50D · SPL
- Neo-Terramycin® 50/50 · SPL
- Neo-Terramycin® 100/100D · SPL
- N140579_Org_12_18_1978.pdf · FOI
- BOVATEC® and TM® · SPL
- MAGNA-TERRAMYCIN® Soluble Powder · SPL
- N046719_Orig_5_6_1998.pdf · FOI
- MGA® and TM® · SPL
- N046718_Orig_5_6_1998.pdf · FOI
- MGA® (liquid) and TM® · SPL
- FOI Summary sN 008-622 Approved December 30, 2019.pdf · FOI
- ucm049519.pdf · FOI
- ucm049517.pdf · FOI
- UCM523939.pdf · FOI
- TERRAMYCIN-343® · SPL
- TERRAMYCIN® · SPL
- TERRAMYCIN® Soluble Powder Concentrate · SPL
- ucm079545.pdf · FOI
- ucm079541.pdf · FOI
- N095143_Org_5_30_96.pdf · FOI
- Terramycin® 10 · SPL
- Terramycin® 30 · SPL
- Terramycin® 50 · SPL
- Terramycin® 100 · SPL
- Terramycin® 200 · SPL
- Terramycin® 200 Granular · SPL
- Terramycin® 100MR · SPL
- FOI Summary oA 200-537 Approved May 30, 2019.pdf · FOI
- Tetroxy®-LA · SPL
- Terramycin® · SPL
- A-200117-Q-0101-OT-AA_foi.pdf · FOI
- A200117_Orig_4_13_1995.pdf · FOI
- Oxytetracycline Injection · SPL
- ucm054894.pdf · FOI
- OXY 500 Calf Bolus · SPL
- OXY 1000 Calf Bolus · SPL
- ucm061595.pdf · FOI
- AGRIMYCIN® 200 · SPL
- ucm069807.pdf · FOI
- N113232_Supp_4_23_1997.pdf · FOI
- N113232-Supp_3_28_1996(2).pdf · FOI
- 113-232 · EA
- 113-232 · FONSI
- Liquamycin® LA-200® · SPL
- ucm061758.pdf · FOI
- Oxytetracycline Injection 200 · SPL
- ucm061589.pdf · FOI
- ucm061587.pdf · FOI
- A200123_Org_2_10_1995.pdf · FOI
- MAXIM-200 · SPL
- ucm061605.pdf · FOI
- ucm061603.pdf · FOI
- A200154_Orig_05_08_1996.pdf · FOI
- Pennox® 200 · SPL
- A200068_Orig_07_31_1995.pdf · FOI
- MAXIM 100 · SPL
- ucm061564.pdf · FOI
- ucm061563.pdf · FOI
- UCM351251.pdf · FOI
- UCM351250.pdf · FOI
- Bio-Mycin® 200 · SPL
- ucm061378.pdf · FOI
- Oxytet 100 · SPL
- Oxy-Tet™ Injection · SPL
- Bio-Mycin C · SPL
- Medamycin® 100 · SPL
- MEDAMYCIN® · SPL
- Oxyject® · SPL
- UCM468906.pdf · FOI
- OXYJECT® 100 · SPL
- Status™ SQ · SPL
- OXY-TET 50™ · SPL
- Bio-Mycin® · SPL
- FOI Summary sN 038-439 Approved April 10, 2023.pdf · FOI
- FOI Summary sN 038-439 Approved November 21, 2018.pdf · FOI
- N038439.UCM143044.July 6.2008.pdf · FOI
- ucm049542.pdf · FOI
- 038-439 · EA
- 038-439 · FONSI
- 038-439 · EA
- 038-439 · FONSI
- Terramycin® 100 for Fish · SPL
- Terramycin® 200 for Fish · SPL
- ucm061599.pdf · FOI
- A200144_Orig_06_26_1995.pdf · FOI
- Tetroxy® HCA-280 · SPL
- Tetroxy® HCA-1772 · SPL
- Tetroxy® HCA-1400 · SPL
- ucm117183.pdf · FOI
- Noromycin® 300 LA · SPL
- N140582_Org_3_15_1988.pdf · FOI
- Biocyl-50 · SPL
- Biocyl-100 · SPL
- Oxytetracycline-50 · SPL
- Rachelle Oxyvet Injection · SPL
- Oxyvet-100 · SPL
- Aquachel-100 · SPL
- Terramycin® 100 · SPL
- Liquamycin® 100 · SPL
- Terramycin® Scours Tablets · SPL
- UCM243040.pdf · FOI
- Hexasol® Injection · SPL
- ucm049522.pdf · FOI
- ucm049521.pdf · FOI
- N008804_Supp_3_14_1996.pdf · FOI
- TM-50® · SPL
- TM-50® D · SPL
- TM-100® · SPL
- TM-100®D · SPL
- ucm118005.pdf · FOI
- Mecadox® and Terramycin® · SPL
- UCM283519.pdf · FOI
- ucm069857.pdf · FOI
- N130435_Supp_12_10_1993.pdf · FOI
- 130-435 · EA
- 130-435 · FONSI
- Oxytet® Soluble · SPL
- OXYMarine™ · SPL
- UCM436419.pdf · FOI
- A200146_Supp_8_15_1996.pdf · FOI
- A200146_Orig_04_22_1994.pdf · FOI
- Tetroxy® 25 · SPL
- ucm061679.pdf · FOI
- ucm061678.pdf · FOI
- ucm061676.pdf · FOI
- Tetroxy® 343 · SPL
- UCM478012.pdf · FOI
- TM® plus Bio-Cox® · SPL
- TM® plus Robenz® · SPL
- A200096_Orig_11_25_1994.pdf · FOI
- Sacox® / Terramycin® · SPL
- ucm061380.pdf · FOI
- Tetroxy® Aquatic · SPL
- ucm061580.pdf · FOI
- ucm061578.pdf · FOI
- A200066_Orig_07_15_1994.pdf · FOI
- AGRIMYCIN®-343 · SPL
- N038200_Supp_7_10_1993.pdf · FOI
- OXY WS™ · SPL
- UCM252253.pdf · FOI
- ucm061570.pdf · FOI
- ucm061566.pdf · FOI
- ucm061565.pdf · FOI
- Pennox 343® · SPL
- Aquachel 100 mg · SPL
- UCM061648.pdf · FOI
- UCM061645.pdf · FOI
- Geomycin 200 · SPL
- Liquamycin® Injectable · SPL
- Terramycin® Injectable · SPL
- Liquamycin® Intramuscular · SPL
- Liquimast Solution for Mastitis · SPL
- ucm061757.pdf · FOI
- Oxytetracycline Hydrochloride Soluble Powder · SPL
- Oxytetracycline Premix · SPL
- Purina® Mix-R-Mycin Concentrate · SPL
- Terra-Cortril Spray · SPL
- Liqua-Cortril Spray · SPL
- Terramycin® Egg Formula · SPL
- Terramycin® Premix · SPL
- Terramycin® Vet Capsules · SPL
- TM®-10 Premix · SPL
- TM®-5 Antibiotic Feed Supplement · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2539/Coban%E2%84%A2/TM%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2212/Neo-Oxy%2050/50%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2211/Neo-Oxy%20100/100%20MR%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2028/Neo-Terramycin%C2%AE%20100/100 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2031/Neo-Terramycin%C2%AE%2050/50D · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2030/Neo-Terramycin%C2%AE%2050/50 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2029/Neo-Terramycin%C2%AE%20100/100D · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1726 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2176/BOVATEC%C2%AE%20and%20TM%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1184/MAGNA-TERRAMYCIN%C2%AE%20Soluble%20Powder · document · SPL
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 9, 2026, 3:15 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero-day slaughter withdrawal in swine. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 0010-4753-01 | 0010 | - | |
| 0010-4753-02 | 0010 | - | |
| 0010-4753-03 | 0010 | - | |
| 13985-035-02 | 13985 | - | |
| 13985-035-04 | 13985 | - | |
| 13985-035-05 | 13985 | - | |
| 13985-944-10 | 13985 | - | |
| 13985-944-25 | 13985 | - | |
| 13985-944-50 | 13985 | - | |
| 23243-6759-1 | 23243 | - | |
| 23243-6759-2 | 23243 | - | |
| 23243-6759-3 | 23243 | - | |
| 23243-7430-4 | 23243 | - | |
| 23243-7430-5 | 23243 | - | |
| 23243-7430-6 | 23243 | - | |
| 43457-528-25 | 43457 | - | |
| 46066-007-02 | 46066 | - | |
| 46066-007-04 | 46066 | - | |
| 46066-007-05 | 46066 | - | |
| 46066-553-03 | 46066 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
N140579_Org_12_18_1978.pdf
• FOI summary • Official
• Nov. 12, 2024
FDA FOI summary for application 140579
-
N046719_Orig_5_6_1998.pdf
• FOI summary • Official
• Nov. 12, 2024
FDA FOI summary for application 46719
-
N046718_Orig_5_6_1998.pdf
• FOI summary • Official
• Nov. 12, 2024
FDA FOI summary for application 46718
-
UCM523939.pdf
• FOI summary • Official
• Nov. 12, 2024
FDA FOI summary for application 8622
-
ucm049517.pdf
• FOI summary • Official
• Nov. 12, 2024
FDA FOI summary for application 8622
-
ucm049519.pdf
• FOI summary • Official
• Nov. 12, 2024
FDA FOI summary for application 8622
-
FOI Summary sN 008-622 Approved December 30, 2019.pdf
• FOI summary • Official
• Nov. 12, 2024
FDA FOI summary for application 8622
-
N095143_Org_5_30_96.pdf
• FOI summary • Official
• Aug. 21, 2024
FDA FOI summary for application 95143
-
ucm079541.pdf
• FOI summary • Official
• Aug. 21, 2024
FDA FOI summary for application 95143
-
ucm079545.pdf
• FOI summary • Official
• Aug. 21, 2024
FDA FOI summary for application 95143
-
FOI Summary oA 200-537 Approved May 30, 2019.pdf
• FOI summary • Official
• July 3, 2024
FDA FOI summary for application 200537
-
A200117_Orig_4_13_1995.pdf
• FOI summary • Official
• April 30, 2024
FDA FOI summary for application 200117
-
A-200117-Q-0101-OT-AA_foi.pdf
• FOI summary • Official
• April 30, 2024
FDA FOI summary for application 200117
-
ucm054894.pdf
• FOI summary • Official
• Aug. 25, 2023
FDA FOI summary for application 141002
-
ucm061595.pdf
• FOI summary • Official
• June 15, 2023
FDA FOI summary for application 200128
-
N113232-Supp_3_28_1996(2).pdf
• FOI summary • Official
• June 15, 2023
FDA FOI summary for application 113232
-
N113232_Supp_4_23_1997.pdf
• FOI summary • Official
• June 15, 2023
FDA FOI summary for application 113232
-
ucm069807.pdf
• FOI summary • Official
• June 15, 2023
FDA FOI summary for application 113232
-
ucm061758.pdf
• FOI summary • Official
• June 14, 2023
FDA FOI summary for application 200306
-
A200123_Org_2_10_1995.pdf
• FOI summary • Official
• June 12, 2023
FDA FOI summary for application 200123
-
ucm061587.pdf
• FOI summary • Official
• June 12, 2023
FDA FOI summary for application 200123
-
ucm061589.pdf
• FOI summary • Official
• June 12, 2023
FDA FOI summary for application 200123
-
A200154_Orig_05_08_1996.pdf
• FOI summary • Official
• June 7, 2023
FDA FOI summary for application 200154
-
ucm061603.pdf
• FOI summary • Official
• June 7, 2023
FDA FOI summary for application 200154
-
ucm061605.pdf
• FOI summary • Official
• June 7, 2023
FDA FOI summary for application 200154
-
A200068_Orig_07_31_1995.pdf
• FOI summary • Official
• May 26, 2023
FDA FOI summary for application 200068
-
UCM351250.pdf
• FOI summary • Official
• May 24, 2023
FDA FOI summary for application 200008
-
UCM351251.pdf
• FOI summary • Official
• May 24, 2023
FDA FOI summary for application 200008
-
ucm061563.pdf
• FOI summary • Official
• May 24, 2023
FDA FOI summary for application 200008
-
ucm061564.pdf
• FOI summary • Official
• May 24, 2023
FDA FOI summary for application 200008
-
ucm061378.pdf
• FOI summary • Official
• May 23, 2023
FDA FOI summary for application 200452
-
UCM468906.pdf
• FOI summary • Official
• May 1, 2023
FDA FOI summary for application 97452
-
ucm049542.pdf
• FOI summary • Official
• May 1, 2023
FDA FOI summary for application 38439
-
N038439.UCM143044.July 6.2008.pdf
• FOI summary • Official
• May 1, 2023
FDA FOI summary for application 38439
-
FOI Summary sN 038-439 Approved November 21, 2018.pdf
• FOI summary • Official
• May 1, 2023
FDA FOI summary for application 38439
-
FOI Summary sN 038-439 Approved April 10, 2023.pdf
• FOI summary • Official
• May 1, 2023
FDA FOI summary for application 38439
-
A200144_Orig_06_26_1995.pdf
• FOI summary • Official
• Jan. 12, 2023
FDA FOI summary for application 200144
-
ucm061599.pdf
• FOI summary • Official
• Jan. 12, 2023
FDA FOI summary for application 200144
-
ucm117183.pdf
• FOI summary • Official
• Nov. 18, 2022
FDA FOI summary for application 141143
-
N140582_Org_3_15_1988.pdf
• FOI summary • Official
• Nov. 16, 2022
FDA FOI summary for application 140582
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used f… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Anal sac disorder, Behavioural disorder NOS, Corneal ulcer, Hives (see also 'Skin'), Injection site pain, Leucocytosis NOS. (Official, 2026-02-12)
- usage: It is used in dogs for the treatment of bacterial pneumonia caused by Brucella bronchiseptica, tonsillitis caused by Streptococcus hemolyticus, bacterial enter… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Coban™/TM®
VFD
Monensin Oxytetracycline
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 99006 | Approved | Nov 5, 2025 |
|
Neo-Oxy 50/50® Neo-Oxy 100/100 MR®
VFD
Neomycin Sulfate Oxytetracycline Hydrochloride
Type A Medicated Article
• Oral
|
Pharmgate Inc. | NADA 138-939 | Approved | Oct 15, 2025 |
|
Neo-Terramycin® 100/100 Neo-Terramycin® 50/50D Neo-Terramycin® 50/50 Neo-Terramycin® 100/100D
VFD
Neomycin Sulfate Oxytetracycline
Oral
|
Phibro Animal Health Corp. | NADA 94975 | Approved | Jan 16, 2025 |
|
BOVATEC® and TM®
VFD
Lasalocid Oxytetracycline (Monoalkyl Trimethyl Ammonium Salt)
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 140-579 | Approved | Nov 12, 2024 |
|
MAGNA-TERRAMYCIN® Soluble Powder
RX
Carbomycin Oxytetracycline Hydrochloride
Soluble Powder
• Oral
|
Phibro Animal Health Corp. | NADA 32946 | Approved | Nov 12, 2024 |
|
MGA® and TM®
VFD
Melengestrol Acetate Oxytetracycline
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 46719 | Approved | Nov 12, 2024 |
|
MGA® (liquid) and TM®
VFD
Melengestrol Acetate Oxytetracycline
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 46718 | Approved | Nov 12, 2024 |
|
TERRAMYCIN-343® TERRAMYCIN® TERRAMYCIN® Soluble Powder Concentrate
RX
Oxytetracycline Hydrochloride
Powder for solution
• Oral, Immersion
|
Phibro Animal Health Corp. | NADA 8622 | Approved | Nov 12, 2024 |
|
Terramycin® 10 Terramycin® 30 Terramycin® 50 Terramycin® 100 Terramycin® 200 Terramycin® 200 Granular Terramycin® 100MR
VFD
Oxytetracycline
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 95143 | Approved | Aug 21, 2024 |
|
Tetroxy®-LA
RX
Oxytetracycline
Injectable Solution
• Intramuscular, Intravenous, Subcutaneous
|
Bimeda Animal Health Limited | ANADA 200-537 | Approved | Jul 3, 2024 |
|
Terramycin®
RX
Oxytetracycline Hydrochloride Polymyxin B Sulfate
Ointment
• Ophthalmic
|
Zoetis Inc. | NADA 8763 | Approved | Jul 1, 2024 |
|
Oxytetracycline Injection
RX
Oxytetracycline
Injectable Solution
• Intravenous, Intramuscular
|
Bimeda Animal Health Limited | ANADA 200-117 | Approved | Apr 30, 2024 |
|
OXY 500 Calf Bolus OXY 1000 Calf Bolus
OTC
Oxytetracycline Hydrochloride
Bolus
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 141-002 | W | Aug 25, 2023 |
|
AGRIMYCIN® 200
RX
Oxytetracycline Dihydrate
Injectable Solution
• Intravenous, Subcutaneous, Intramuscular
|
Huvepharma EOOD | ANADA 200-128 | Approved | Jun 15, 2023 |
|
Liquamycin® LA-200®
RX
Oxytetracycline
Injectable Solution
• Subcutaneous, Intravenous, Intramuscular
|
Zoetis Inc. | NADA 113-232 | Approved | Jun 15, 2023 |
|
Oxytetracycline Injection 200
RX
Oxytetracycline
Injectable Solution
• Subcutaneous, Intravenous, Intramuscular
|
Norbrook Laboratories, Ltd. | ANADA 200-306 | Approved | Jun 14, 2023 |
|
MAXIM-200
RX
Oxytetracycline
Injectable Solution
• Subcutaneous, Intravenous, Intramuscular
|
Huvepharma EOOD | ANADA 200-123 | Approved | Jun 12, 2023 |
|
Pennox® 200
RX
Oxytetracycline
Injectable Solution
• Intravenous, Subcutaneous, Intramuscular
|
Pharmgate Inc. | ANADA 200-154 | Approved | Jun 7, 2023 |
|
MAXIM 100
RX
Oxytetracycline
Injectable Solution
• Intravenous
|
Huvepharma EOOD | ANADA 200-068 | Approved | May 26, 2023 |
|
Bio-Mycin® 200
RX
Oxytetracycline
Injectable Solution
• Subcutaneous, Intramuscular, Intravenous
|
Boehringer lngelheim Animal Health USA, Inc. | ANADA 200-008 | Approved | May 24, 2023 |
|
Oxytet 100
RX
Oxytetracycline
Injectable Solution
• Intravenous
|
Norbrook Laboratories, Ltd. | ANADA 200-452 | Approved | May 23, 2023 |
|
Oxy-Tet™ Injection Bio-Mycin C
RX/OTC
Oxytetracycline Hydrochloride
Liquid (Solution)
• Intramuscular
|
Boehringer lngelheim Animal Health USA Inc. | NADA 95642 | W | May 3, 2023 |
|
Medamycin® 100 MEDAMYCIN®
RX
Oxytetracycline
Injectable Solution
• Intramuscular
|
Cronus Pharma Specialities India Private Ltd. | NADA 108-963 | Approved | May 1, 2023 |
|
Oxyject®
RX
Oxytetracycline
Injectable Solution
• Intramuscular
|
Cronus Pharma Specialities India Private Ltd. | NADA 45143 | Approved | May 1, 2023 |
|
OXYJECT® 100 Status™ SQ
RX
Oxytetracycline
Injectable Solution
• Intramuscular
|
Cronus Pharma Specialities India Private Ltd. | NADA 97452 | Approved | May 1, 2023 |
|
OXY-TET 50™ Bio-Mycin®
RX
Oxytetracycline
Injectable Solution
• Intramuscular, Intravenous
|
Cronus Pharma Specialities India Private Ltd. | NADA 47278 | Approved | May 1, 2023 |
|
Terramycin® 100 for Fish Terramycin® 200 for Fish
VFD
Oxytetracycline Dihydrate
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 38439 | Approved | May 1, 2023 |
|
Tetroxy® HCA-280 Tetroxy® HCA-1772 Tetroxy® HCA-1400
RX
Oxytetracycline Hydrochloride
Soluble Powder
• Oral
|
Bimeda Animal Health Limited | ANADA 200-144 | Approved | Jan 12, 2023 |
|
Noromycin® 300 LA
RX
Oxytetracycline Dihydrate
Solution
• Intravenous, Subcutaneous, Intramuscular
|
Norbrook Laboratories, Ltd. | NADA 141-143 | Approved | Nov 18, 2022 |
|
Biocyl-50 Biocyl-100
RX
Oxytetracycline Hydrochloride
Injectable Solution
• Intravenous
|
Bimeda Animal Health Limited | NADA 140-582 | Approved | Nov 16, 2022 |
|
Oxytetracycline-50
RX
Oxytetracycline Hydrochloride
Liquid (Solution)
• Intramuscular
|
Huvepharma EOOD | NADA 48287 | Approved | Sep 26, 2022 |
|
Rachelle Oxyvet Injection
RX
Oxytetracycline Hydrochloride
Liquid (Solution)
• Intravenous, Intramuscular
|
Zoetis Inc. | NADA 91127 | Approved | Sep 26, 2022 |
|
Oxyvet-100 Aquachel-100
RX
Oxytetracycline Hydrochloride
Liquid (Solution)
• Intravenous
|
Zoetis Inc. | NADA 99402 | Approved | Aug 15, 2022 |
|
Terramycin® 100 Liquamycin® 100
RX
Oxytetracycline Hydrochloride
Liquid (Solution)
• Intramuscular
|
Zoetis Inc. | NADA 94114 | Approved | Jul 29, 2022 |
|
Terramycin® Scours Tablets
RX
Oxytetracycline Hydrochloride
Tablet
• Oral
|
Zoetis Inc. | NADA 11060 | Approved | Jul 29, 2022 |
|
Hexasol® Injection
RX
Flunixin Meglumine Oxytetracycline
Liquid (Solution)
• Intramuscular, Subcutaneous
|
Norbrook Laboratories, Ltd. | NADA 141-312 | Approved | Mar 4, 2022 |
|
TM-50® TM-50® D TM-100® TM-100®D
VFD
Oxytetracycline Hydrochloride
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 8804 | Approved | Jul 13, 2021 |
|
Mecadox® and Terramycin®
VFD
Carbadox Oxytetracycline
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 141-211 | Approved | Aug 17, 2020 |
|
Oxytet® Soluble OXYMarine™
RX
Oxytetracycline Hydrochloride
Soluble Powder
• Immersion
|
Huvepharma EOOD | NADA 130-435 | Approved | Jun 12, 2019 |
|
Tetroxy® 25
RX
Oxytetracycline Hydrochloride
Soluble Powder
• Oral
|
Bimeda Animal Health Limited | ANADA 200-146 | Approved | Mar 17, 2019 |
|
Tetroxy® 343
RX
Oxytetracycline Hydrochloride
Powder
• Oral, Immersion
|
Bimeda Animal Health Limited | ANADA 200-247 | Approved | Mar 17, 2019 |
|
TM® plus Bio-Cox®
VFD
Oxytetracycline Salinomycin Sodium
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 140-448 | Approved | Dec 18, 2018 |
|
TM® plus Robenz®
VFD
Oxytetracycline Robenidine Hydrochloride
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 101-666 | Approved | Dec 18, 2018 |
|
Sacox® / Terramycin®
VFD
Oxytetracycline Salinomycin Sodium
Type A Medicated Article
• Oral
|
Huvepharma EOOD | ANADA 200-096 | Approved | Oct 22, 2018 |
|
Tetroxy® Aquatic
RX
Oxytetracycline Hydrochloride
Liquid (Solution)
• Immersion
|
Bimeda Animal Health Limited | ANADA 200-460 | Approved | Oct 2, 2018 |
|
AGRIMYCIN®-343
RX
Oxytetracycline Hydrochloride
Soluble Powder
• Oral
|
Huvepharma EOOD | ANADA 200-066 | Approved | Jul 2, 2018 |
|
OXY WS™
RX
Oxytetracycline Hydrochloride
Soluble Powder
• Oral
|
Phibro Animal Health Corp. | NADA 38200 | Approved | May 15, 2017 |
|
Pennox 343®
RX
Oxytetracycline Hydrochloride
Soluble Powder
• Immersion, Oral
|
Pharmgate Inc. | ANADA 200-026 | Approved | Jan 3, 2017 |
|
Aquachel 100 mg
RX
Lidocaine Oxytetracycline Hydrochloride
Liquid (Solution)
• Intramuscular
|
Zoetis Inc. | NADA 49948 | Approved | Jun 1, 2016 |
|
Geomycin 200
OTC
Oxytetracycline
Liquid (Solution)
• Subcutaneous, Intramuscular, Intravenous
|
Pliva, d. d. | ANADA 200-232 | W | Jun 1, 2016 |
|
Liquamycin® Injectable Terramycin® Injectable
RX
Oxytetracycline Hydrochloride
Liquid (Solution)
• Intravenous, Intramuscular, Subcutaneous
|
Zoetis Inc. | NADA 8769 | Approved | Jun 1, 2016 |
|
Liquamycin® Intramuscular
RX
Lidocaine Oxytetracycline Hydrochloride
Liquid (Solution)
• Intramuscular
|
Zoetis Inc. | NADA 13146 | Approved | Jun 1, 2016 |
|
Liquimast Solution for Mastitis
OTC
Oxytetracycline Hydrochloride
|
Pfizer, Inc. | NADA 11034 | W | Jun 1, 2016 |
|
Oxytetracycline Hydrochloride Soluble Powder
OTC
Oxytetracycline Hydrochloride
Liquid (Solution)
• Oral
|
Vetoquinol N.-A., Inc. | ANADA 200-305 | W | Jun 1, 2016 |
|
Oxytetracycline Premix
OTC
Oxytetracycline Hydrochloride
|
Purina Mills, Inc. | NADA 94959 | W | Jun 1, 2016 |
|
Purina® Mix-R-Mycin Concentrate
OTC
Oxytetracycline Hydrochloride
|
Purina Mills, Inc. | NADA 94960 | W | Jun 1, 2016 |
|
Terra-Cortril Spray Liqua-Cortril Spray
RX
Hydrocortisone Oxytetracycline Hydrochloride
Spray
• Topical
|
Zoetis Inc. | NADA 13293 | Approved | Jun 1, 2016 |
|
Terramycin® Egg Formula
OTC
Oxytetracycline Hydrochloride
|
Pfizer, Inc. | NADA 10661 | W | Jun 1, 2016 |
|
Terramycin® Premix
OTC
Oxytetracycline Hydrochloride
Medicated Feed
• Oral
|
Pfizer, Inc. | NADA 103-758 | W | Jun 1, 2016 |
|
Terramycin® Vet Capsules
RX
Oxytetracycline Hydrochloride
Capsule
• Oral
|
Zoetis Inc. | NADA 7879 | Approved | Jun 1, 2016 |
|
TM®-10 Premix
OTC
Oxytetracycline Hydrochloride
|
Pfizer, Inc. | NADA 13470 | W | Jun 1, 2016 |
|
TM®-5 Antibiotic Feed Supplement
OTC
Oxytetracycline (Monoalkyl Trimethyl Ammonium Salt)
|
Pfizer, Inc. | NADA 8696 | W | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; and for the control of complicated chronic respiratory disease (CRD or air-sac infection) caused by Mycoplasma gallisepticum and Escherichia coli in broiler chickens.
90 or 110 grams monensin and 200 grams oxytetracycline per ton of Type C medicated feed.
Feed continuously as sole ration. Withdraw 72 hours before slaughter. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not allow horses other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses andguinea fowl has been fatal. In the absence of coccidiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced weight gain. Not for replacement chickens intended to become breeding chickens.
As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; and as an aid in the reduction of mortality due to air-sacculitis (air-sac infection) caused by Escherichia coli sensitive to oxytetracycline in broiler chickens.
90 to 110 grams monensin and 500 grams oxytetracycline per ton of Type C medicated feed.
Feed for 5 days as the sole ration. Treat at first clinical signs of disease. Withdraw 72 hours before slaughter. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not allow horses other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of cocciodiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced weight gain. Not for replacement chickens intended to become breeding chickens.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to oxytetracycline.
400 g/ton
Feed continuously for 7-14 days; do not feed to chickens producing eggs for human consumption; in low calcium feed, withdraw 3 days before slaughter.
For reduction of mortality due to air sacculitis (air sac infection) caused by Escherichia coli susceptible to oxytetracycline.
500 g/ton
Feed continuously for 5 days; do not feed to chickens producing eggs for human consumption; withdraw 24 hours before slaughter; in low calcium feed, withdraw 3 days before slaughter.
For control of infectious synovitis caused by Mycoplasma synoviae, control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline.
100 to 200 g/ton
Feed continuously for 7-14 days; do not feed to chickens producing eggs for human consumption; in low calcium feed, withdraw 3 days before slaughter.
For control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to oxytetracycline.
25 mg/lb body weight/day
Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; do not feed to turkeys producing eggs for human consumption.
For control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline.
100 g/ton
Feed continuously for 7 to 14 days; do not feed to turkeys producing eggs for human consumption.
For control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
200 g/ton
Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; do not feed to turkeys producing eggs for human consumption.
For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.
10 mg/lb/body weight/day
Feed continuously for 7 to 14 days; withdraw 5 days before slaughter.
For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira Pomona susceptible to oxytetracycline.
10 mg/lb/body weight/day
Feed continuously for not more than 14 days; withdraw 5 days before slaughter.
For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.
10 mg/lb body weight/day
Feed continuously for 7-14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Withdraw 5 days before slaughter.
For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.
10 mg/lb body weight/day
Feed continuously for 7 to 14 days; in milk replacers or starter feed. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. A withdrawal period has not been established for use in pre-ruminating calves. Do not use in calves to be processed for veal.
For the reduction of the incidence of liver abscesses.
75 mg/head/day
Feed continuously.
For the prevention and treatment of the early stages of shipping fever complex.
0.5 to 2.0 g/head/day
Feed 3-5 days before and after arrival in feedlots. A withdrawal period has not been established for use in pre-ruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older.
For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin.
10 mg/lb body weight/day
Feed continuously for 7-14 days in feed or milk replacers. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. A withdrawal period has not been established for use in pre-ruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. Withdraw 5 days before slaughter.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
50 g [or 100 g] neomycin sulfate /lb
Feed continuously for 7 to 14 days. Do not feed to chickens producing eggs for human consumption. In low calcium feed, withdraw 3 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For reduction of mortality due to air sacculitis (air sac infection) caused by E. coli susceptible to oxytetracycline.
500 g/ton
Feed continuously for 5 days. Do not feed to chickens producing eggs for human consumption. Withdraw 24 hours before slaughter. In low calcium feed, withdraw 3 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For control of chronic respiratory disease (CRD) and air sac infection caused by M. gallisepticum and Escherichia coli susceptible to oxytetracycline.
400 g/ton
Feed continuously for 7 to 14 days. Do not feed to chickens producing eggs for human consumption. In low calcium feed, withdraw 3 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter. Do not feed to turkeys producing eggs for human consumption. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Feed continuously for 7 to 14 days. Do not feed to turkeys producing eggs for human consumption. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter. Do not feed to turkeys producing eggs for human consumption. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Treatment of bacterial enteritis caused by E. coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
10 mg/lb of body weight daily.
Feed continuously for 7-14 days. 5-day withdrawal before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline
Feed continuously for not more than 14 days. Withdraw 5 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
10 mg/lb of body weight daily
Feed continuously for 7-14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Feed continuously for 7 to 14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. Withdraw 5 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For reduction of liver condemnation due to liver abscesses.
Feed continuously. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Calves and beef and non-lactating dairy cattle: For treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
10 mg/lb body weight (BW)
Feed continuously for 7 to 14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. Withdraw 5 days before slaughter. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For prevention and treatment of the early stages of shipping fever complex.
0.5 to 2.0 g/head/day
Feed 3 to 5 days before and after arrival in feedlots. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For improved feed efficiency and for the reduction of incidence of liver abscesses in cattle fed in confinement for slaughter.
Feed continuously 10 to 30 g/ton lasalocid to provide 100 to 360 mg lasalocid per head per day and 7.5 g/ton oxytetracycline to provide 75 mg oxytetracycline per head per day.
The safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For increased rate of weight gain, improved feed efficiency, and for the reduction of incidence of liver abscesses in cattle fed in confinement for slaughter.
Feed continuously 25 to 30 g/ton lasalocid to provide 250 to 360 mg lasalocid per head per day and 7.5 g/ton oxytetracycline to provide 75 mg oxytetracycline per head per day.
The safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
As an aid in the prevention and treatment of complicated chronic respiratory disease (air-sac infection) caused by Mycoplasma gallisepticum and secondary bacterial organisms associated with chronic respiratory disease such as E. coli.
Administer for not more than 5 days. Not for use in chickens producing eggs for human consumption. Withdraw 24 hours before slaughter.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat) and for the reduction of incidence of liver abscesses in heifers being fed in confinement for slaughter.
Feed 0.25 to 2.0 g/ton melengestrol acetate to heifers at a rate of 0.5 to 2.0 lb/hd/day as a top dress or mixed into a complete feed to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 75 to 300 g/ton oxytetracycline to provide 75 mg oxytetracycline per head per day. Melengestrol acetate and oxytetracycline may be fed continuously throughout the time the heifers are being grown and finished for slaughter.
Not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent thepossibility that the heifers may come into estrus (heat) at the time of loading.Do not mix with oxytetracycline as a common liquid feed supplement.
Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat) and for the reduction of incidence of liver abscesses in heifers being fed in confinement for slaughter.
Feed 0.25 to 2.0 g/ton melengestrol acetate to heifers at a rate of 0.5 to 2.0 lb/hd/day as a top dress or mixed into a complete feed to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 75 to 300 g/ton oxytetracycline to provide 75 mg oxytetracycline per head per day. Continue feeding throughout the time the heifers are being grown and finished for slaughter.
Not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading. Do not mix with oxytetracycline as a common liquid feed supplement. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and E. coli susceptible to oxytetracycline; control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline.
Control and treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero-day slaughter withdrawal in swine.
Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero–day slaughter withdrawal in swine.
Control and treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline.
Control and treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline.
Prepare a fresh solution daily. Administer up to 14 days.Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Withdraw 5 days before slaughter.
Control and treatment of American foul brood caused by Paenibacillus larvae.
The drug is administered in 3 applications of sugar syrup or 3 dustings at 4- to 5- day intervals. The drug should be fed early in the spring or fall and consumed by the bees before main honey flow begins to avoid contamination of production honey. Remove at least 6 weeks prior to main honey flow. Dusting of uncapped brood cells has been reported to cause death of larval honey bees. Do not dust uncapped brood cells.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For control of infectious synovitis caused by Mycoplasma synoviae; control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline.
100 to 200 grams per ton of feed.
Feed continuously for 7 to 14 days. At 500 g/ton level,withdraw 24 hours before slaughter. Zero-day withdrawal period for lower use levels. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not administer to chickens producing eggs for human consumption.
For control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to oxytetracycline.
400 grams per ton of feed.
Feed continuously for 7 to 14 days. At 500 g/ton level, withdraw 24 hours before slaughter. Zero-day withdrawal period for lower use levels. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not administer to chickens producing eggs for human consumption.
For reduction of mortality due to air sacculitis (air-sac-infection) caused by Escherichia coli susceptible to oxytetracycline.
500 grams per ton of feed.
Feed continuously for 5 days. At 500 g/ton level, withdraw 24 hours before slaughter. Zero-day withdrawal period for lower use levels. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not administer to chickens producing eggs for human consumption.
For control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline.
100 grams per ton of feed.
Feed continuously for 7 to 14 days. Do not administer to turkeys producing eggs for human consumption.
For control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
200 grams per ton of feed.
Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter. Do not administer to turkeys producing eggs for human consumption.
For control of complicating bacterial organisms associated with bluecomb (transmissible enteritis; coronaviral enteritis) susceptible to oxytetracycline.
25 milligrams per pound of body weight daily.
Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter. Do not administer to turkeys producing eggs for human consumption.
For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
10 milligrams per pound of body weight daily.
Feed continuously for 7 to 14 days.
For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline.
10 milligrams per pound of body weight daily.
Feed continuously for 14 days.
For growing cattle (over 400 lb) for the reduction of the incidence of liver abscesses.
75 milligrams per head per day.
Feed continuously.
For prevention and treatment of the early stages of shipping fever complex.
0.5 to 2.0 grams per head per day.
Feed 3 to 5 days before and after arrival in feedlots.
For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline.
10 milligrams per pound of body weight daily.
Feed continuously for 7 to 14 days. Zero-day withdrawal time.
For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline.
10 milligrams per pound of body weight daily.
Feed continuously for 7 to 14 days in milk replacer or starter feed. Zero-day withdrawal time.
For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
10 milligrams per pound of body weight daily.
Feed continuously for 7 to 14 days. Withdrawal 5 days before slaughter.
For control of American Foulbrood caused by Paenibacillus larvae, and European Foulbrood caused by Streptococcus pluton susceptible to oxytetracycline.
200 milligrams per colony.
Remove at least 6 weeks prior to main honey flow.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment of the following conditions : 1) bacterial pneumonia caused by Pasteurella spp. (shipping fever) in calves and yearlings, where retreatment is impractical due to husbandry conditions, such as cattle on range, or where repeated restraint is inadvisable; 2) infectious bovine keratoconjunctivitis (pinkeye) cause by Moraxella bovis.
A single dosage of 9 milligrams per pound of body weight administered by subcutaneous injection.
For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Haemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
3 to 5 milligrams of oxytetracycline per pound of body weight per day, administered by subcutaneous or intravenous injection. In the treatment of severe foot rot and advanced cases of other indicated diseases, a dosage level of 5 milligrams per pound of body weight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
For the treatment of bacterial pneumonia caused by Pasteurella multocida, where retreatment is impractical due to husbandry conditions or where repeated restraint is inadvisable.
A single dosage of 9 milligrams of per pound of body weight administered intramuscularly.
For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day administered by intramuscular injection.
Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
As an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 mg of oxytetracycline per lb of body weight administered once by intramuscular injection approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
ointment contains oxytetracycline HCl equivalent to 5 mg of
oxytetracycline and 10,000 units of polymyxin B as the sulfate.
Terramycin® is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, including infections due to streptococci, rickettsiae, E. coli, and A.aerogenes, such as conjunctivitis, keratitis, pink eye, corneal ulcer, blepharitis in dogs, cats, cattle, sheep, and horses; ocular infections due to secondary bacterial complications of distemper in dogs, and bacterial inflammatory conditions whichmay occur secondary to other infectious diseases in the above species.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
As an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli
3 mg of oxytetracycline per lb of body weight administered once by intramuscular injection approximately 8 hours before farrowing or immediately after completion of farrowing.
For the treatment of the following conditions : 1) bacterial pneumonia caused by Pasteurella spp. (shipping fever) in yearlings, where re-treatment is impractical due to husbandry conditions, such as cattle on range, or where repeated restraint is inadvisable; 2) infectious bovine keratoconjunctivitis (pinkeye) cause by Moraxella bovis.
A single dosage of 9 milligrams per pound of body weight administered intramuscularly.
For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Hemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
3 to 5 milligrams of oxytetracycline per pound of body weight per day, administered by intravenous or intramuscular injection. In the treatment of severe foot rot and advanced cases of other indicated diseases, a dosage level of 5 milligrams per pound of body weight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
For the treatment of bacterial pneumonia caused by Pasteurella multocida, where re-treatment is impractical due to husbandry conditions or where repeated restraint is inadvisable.
A single dosage of 9 milligrams of per pound of body weight administered intramuscularly.
For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day administered by intramuscular injection. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment of the following conditions: 1) bacterial pneumonia caused by Pasteurella spp. (shipping fever) in calves and yearlings, where retreatment is impractical due to husbandry conditions, such as cattle on range, or where repeated restraint is inadvisable; 2) infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis.
A single dosage of 9 milligrams oxytetracycline per pound of body weight administered subcutaneously.
For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Haemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
3 to 5 milligrams of oxytetracycline per pound of body weight per day, administered by subcutaneous or intravenous injection. In the treatment of severe foot rot and advanced cases of other indicated diseases, a dosage of 5 milligrams per pound of body weight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
For the treatment of bacterial pneumonia caused by Pasteurella multocida, where retreatment is impractical due to husbandry conditions or where repeated restraint is inadvisable.
A single dosage of 9 milligrams oxytetracycline per pound of body weight administered intramuscularly.
For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day administered by intramuscular injection. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
As an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 mg of oxytetracycline per lb of body weight administered once by intramuscular injection approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Treatment of infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; and in the treatment of the following conditions where retreatment is impractical due to husbandry conditions, such as cattle on range, or where their repeated restraint is inadvisable: bacterial pneumonia caused by Pasteurella spp. (shipping fever) in calves and yearlings, and anaplasmosis caused by Anaplasma marginale.
A single dosage of 9 milligrams oxytetracycline per pound of body weight administered intramuscularly or subcutaneously.
For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Hemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; anaplasmosis caused by Anaplasma marginale; anthrax caused by Bacillus anthracis; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
3 to 5 milligrams of oxytetracycline per pound of body weight per day, administered by intravenous, subcutaneous, or intramuscular injection. In the treatment of severe foot-rot and advanced cases of other indicated diseases, a dosage of 5 milligrams per pound of body weight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
For the treatment of bacterial pneumonia caused by Pasteurella multocida, where retreatment is impractical due to husbandry conditions or where repeated restraint is inadvisable.
A single dosage of 9 milligrams of oxytetracycline per pound of body weight administered intramuscularly.
For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day administered by intramuscular injection. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
As an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 mg of oxytetracycline per lb of body weight administered once by intramuscular injection approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment of the following conditions: 1) bacterial pneumonia caused by Pasteurella spp. (shipping fever) in calves and yearlings, where retreatment is impractical due to husbandry conditions, such as cattle on range, or where repeated restraint is inadvisable; 2) infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis.
A single dosage of 9 milligrams oxytetracycline per pound of body weight administered intramuscularly or subcutaneously.
For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Haemophilus spp; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
3 to 5 milligrams of oxytetracycline per pound of body weight per day, administered by intravenous, subcutaneous, or intramuscular injection. In the treatment of severe foot-rot and advanced cases of other indicated diseases, a dosage of 5 milligrams per pound of body weight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
For the treatment of bacterial pneumonia caused by Pasteurella multocida, where re-treatment is impractical due to husbandry conditions or where repeated restraint is inadvisable.
A single dosage of 9 milligrams of oxytetracycline per pound of body weight administered intramuscularly.
For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day administered by intramuscular injection. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
As an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 mg of oxytetracycline per lb of body weight administered once by intramuscular injection approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment of the following conditions: 1) bacterial pneumonia caused by Pasteurella spp. (shipping fever) in calves and yearlings, where retreatment is impractical due to husbandry conditions, such as cattle on range, or where repeated restraint is inadvisable; 2) infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis.
A single dosage of 9 milligrams oxytetracycline per pound of body weight administered intramuscularly or subcutaneously.
For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Hemophilus spp; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot-rot and diphtheria caused by Fusobacterium necrophorum; bacterial bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
3 to 5 milligrams of oxytetracycline per pound of body weight per day, administered by intravenous, subcutaneous, or intramuscular injection. In the treatment of severe foot-rot and advanced cases of other indicated diseases, a dosage of 5 milligrams per pound of body weight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
Where re-treatment for pneumonia is impractical. For the treatment of bacterial pneumonia caused by Pasteurella multocida, where re-treatment is impractical due to husbandry conditions or where repeated restraint is inadvisable.
A single dosage of 9 milligrams oxytetracycline per pound of body weight administered intramuscularly.
For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day administered by intramuscular injection. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
As an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 mg of oxytetracycline per lb of body weight administered once by intramuscular injection approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment of the following conditions: 1) bacterial pneumonia caused by Pasteurella spp. (shipping fever) in calves and yearlings, where retreatment is impractical due to husbandry conditions, such as cattle on range, or where repeated restraint is inadvisable; 2) infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis.
A single dosage of 9 milligrams oxytetracycline per pound of body weight administered subcutaneously.
For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Hemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
3 to 5 milligrams of oxytetracycline per pound of body weight per day, administered by subcutaneous or intravenous injection. In the treatment of severe foot rot and advanced cases of other indicated diseases, a dosage of 5 milligrams per pound of body weight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
For the treatment of bacterial pneumonia caused by Pasteurella multocida, where retreatment is impractical due to husbandry conditions or where repeated restraint is inadvisable.
A single dosage of 9 milligrams oxytetracycline per pound of body weight administered intramuscularly.
For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day administered by intramuscular injection. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
As an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 mg of oxytetracycline per lb of body weight administered once by intramuscular injection approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Treatment of bacterial pneumonia and shipping fever complex associated with Pasteurella spp.; bacterial enteritis (scours) caused by Escherichia coli; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum; wooden tongue caused by Actinobacillus lignieresi; and wound infections, acute metritis, and traumatic injury caused by oxytetracycline susceptible staphylococcal and streptococcal organisms.
3 to 5 milligrams of oxytetracycline per pound of body weight per day (3 to 5 mL per 100 pounds of body weight) by intravenous injection. Severe foot rot and the severe forms of the indicated diseases should be treated with 5 mg per pound of body weight. Treatment should be continued 24 to 48 hours following remission of disease symptoms, not to exceed a total of 4 consecutive days.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
As an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 mg of oxytetracycline per lb of body weight administered once by intramuscular injection approximately 8 hours before farrowing or immediately after completion of farrowing.
For the treatment of the following conditions : 1) bacterial pneumonia caused by Pasteurella spp. (shipping fever) in yearlings, where re-treatment is impractical due to husbandry conditions, such as cattle on range, or where repeated restraint is inadvisable; 2) infectious bovine keratoconjunctivitis (pinkeye) cause by Moraxella bovis.
A single dosage of 9 milligrams per pound of body weight administered intramuscularly or subcutaneously.
Intramuscular administration is not recommended according to Beef Quality Assurance Guidelines.
For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Haemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot-rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
3 to 5 milligrams of oxytetracycline per pound of body weight per day, administered by intravenous, subcutaneous, or intramuscular injection. In the treatment of severe foot rot and advanced cases of other indicated diseases, a dosage level of 5 milligrams per pound of body weight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment. Intramuscular administration is not recommended according to Beef Quality Assurance Guidelines.
For the treatment of bacterial pneumonia caused by Pasteurella multocida, where re-treatment is impractical due to husbandry conditions or where repeated restraint is inadvisable.
A single dosage of 9 milligrams of per pound of body weight administered intramuscularly.
For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day administered by intramuscular injection. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days. Consult your veterinarian if improvement is not noted within 24 to 48 hours of the beginning of treatment.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Treatment of bacterial pneumonia and shipping fever complex associated with Pasteurella spp.; bacterial enteritis (scours) caused by Escherichia coli; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum; wooden tongue caused by Actinobacillus lignieresi; and wound infections, metritis, and traumatic injury caused by oxytetracycline susceptible staphylococcal and streptococcal organisms.
3 to 5 milligrams of oxytetracycline per pound of body weight per day (3 to 5 mL per 100 pounds of body weight)
by intravenous injection. Severe foot rot and the severe forms of the indicated diseases should be treated with 5 mg per pound of body weight. Treatment should be continued 24 to 48 hours following remission of disease symptoms, not to exceed a total of 4 consecutive days.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli, pneumonia caused by Pasteurella multocida, and leptospirosis caused by Leptospira pomona.
As an aid in control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
Treatment of diseases due to oxytetracycline-susceptible organisms as follows: Pneumonia and shipping fever complex associated with Pasteurella species, Hemophilus species, and Klebsiella species, foot-rot and diphtheria caused by Spherophorus necrophorus, bacterial enteritis (scours) caused by Escherichia coli, wooden tongue caused by Actinobacillus lignieresi, leptospirosis caused by Leptospira pomona, and wound infections and acute metritis caused by Staphylococcus species and Streptococcus species. If labeled for use by or on the order of a licensed veterinarian, it may be used for the treatment of anaplasmosis caused by Anaplasma marginale.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Treatment of bacterial pneumonia and shipping fever complex associated with Pasteurella spp.; bacterial enteritis (scours) caused by Escherichia coli; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum; wooden tongue caused by Actinobacillus lignieresi; and wound infections, acute metritis, and traumatic injury caused by oxytetracycline-susceptible staphylococcal and streptococcal organisms.
3 to 5 milligrams of oxytetracycline per pound of body weight per day (3 to 5 mL per 100 pounds of body weight) by intravenous injection. Severe foot rot and the severe forms of the indicated diseases should be treated with 5 mg per pound of body weight. Treatment should be continued 24 to 48 hours following remission of disease symptoms, not to exceed a total of 4 consecutive days.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Treatment of pneumonia and shipping fever complex associated with Pasteurella sp., Hemophilus sp., and Klebsiella sp., bacterial enteritis (scours) caused by Escherichia coli, foot rot and diphtheria caused by Spherophorus necrophorus, wooden tongue caused by Actinobacillus lignieresi, leptospirosis caused by Leptospira pomona, and wound infections, acute metritis, and traumatic injury caused by a variety of bacterial organisms (such as streptococcal and staphylococcal organisms.
3 to 5 milligrams of oxytetracycline per pound of body weight per day (6 to 10 mL per 100 pounds of body weight) by intramuscular injection. For leptospirosis, severe foot rot and severe forms of the indicated diseases, 5 milligrams per pound of body weight per day. Treatment should be continued 24 to 48 hours following remission of disease symptoms, not to exceed a total of 4 consecutive days.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Treatment of pneumonia and shipping fever complex associated with Pasteurella spp., Haemophilus spp., and Klebsiella spp.
3 to 5 milligrams of oxytetracycline per pound of body weight per day (3 to 5 mL per 100 pounds of body weight) by intramuscular, subcutaneous, or intravenous injection. Treatment should be continued 24 to 48 hours following
remission of disease symptoms, not to exceed a total of 4 consecutive days.
For treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli, pneumonia caused by Pasteurella multocida, and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day by intramuscular or intravenous injection.
As an aid in control of porcine colibacillosis (baby pig scours) in suckling pigs caused by Escherichia coli.
3 milligrams of oxytetracycline per pound of body weight by intramuscular injection, approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Treatment of pneumonia and shipping fever complex associated with Pasteurella sp., Hemophilus sp., and Klebsiella sp., foot rot and diphtheria caused by Spherophorus necrophorus, bacterial enteritis (scours) caused by Escherichia coli, wooden tongue caused by Actinobacillus lignieresi, leptospirosis caused by Leptospira pomona, acute metritis, anaplasmosis caused by Anaplasma marginale, and wound infections caused by Staphylococcal and Streptococcal organisms.
3 to 5 milligrams of oxytetracycline per pound of body weight per day (6 to 10 mL per 100 pounds of body weight) by intramuscular or intravenous injection. In severe forms of foot rot, anaplasmosis, and other severe disease forms, 5 milligrams per pound of body weight per
day (10 mL per 100 pounds of body weight). Treatment should be continued 24 to 48 hours following remission of
disease symptoms, not to exceed a total of 4 days.
For treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli, pneumonia caused by Pasteurella multocida, and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams of oxytetracycline per pound of body weight per day (6 to 10 mL per 100 pounds of body weight) by intramuscular injection.
As an aid in control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 milligrams of oxytetracycline per pound of body weight (6 mL per 100 lbs. body weight), by intramuscular injection, approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
250 milligrams of Oxytetracycline per kilogram of fish per day (11.35 grams per 100 pounds of fish per day) in fish feed.
For salmon not over 30 grams body weight. Administer as sole ration for 4 consecutive days.
Control of ulcer disease caused by Haemophilus piscium, furunculosis caused by Aeromonas salmonicida, bacterial hemorrhagic septicemia caused by Aeromonas hydrophila, and pseudomonas disease.
Administer in mixed ration for 10 days.
Control of bacterial hemorrhagic septicemia caused by Aeromonas hydrophila and pseudomonas disease.
Administer in mixed ration for 10 days. Do not administer when water temperature is below 16.7 degrees C (62 degrees F).
3.75 g oxytetracycline per 100 lb of fish per day for 10 days.
Administer in mixed ration for 10 days.
Control of mortality due to columnaris disease associated with Flavobacterium columnare.
3.75 g oxytetracycline per 100 lb of fish per day for 10 days.
Administer in mixed ration for 10 days.
For marking the skeletal tissue
3.75 g oxytetracycline per 100 lb of fish per day for 10 days. Feed for 10 days.
Control of mortality due to columnaris disease associated with Flavobacterium columnare
3.75 g oxytetracycline per 100 lb of fish per day for 10 days. Administer in mixed ration for 10 days. Do not administer when water temperature is below 16.7 degrees C (62 degrees F).
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Control of chronic respiratory disease (CRD) and air sac infections caused by Mycoplasma gallisepticum and E. coli susceptible to oxytetracycline; control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline.
400 to 800 milligrams per gallon of drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
200 to 400 milligrams per gallon of drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
400 milligrams per gallon of drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline.
200 to 400 milligrams per gallon of drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to oxytetracycline.
25 milligrams per pound of body weight in drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control and treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
10 milligrams per pound of body weight daily in drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Use as sole source of OTC. Administer up to 5 days. Do not use for more than 5 consecutive days.
Control and treatment of leptospirosis (reducing the incidence of abortions and shedding of leptospira) caused by Leptospira pomona susceptible to oxytetracycline.
10 milligrams per pound of body weight daily in drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Use as sole source of OTC. Administer up to 5 days. Do not use for more than 5 consecutive days.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For treatment of bacterial pneumonia caused by Pasteurella species (shipping fever) in calves and yearlings where treatment is impractical due to husbandry conditions, such as cattle on range, or where their repeated restraint is inadvisable; or for treatment of infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis.
9 to 13.6 milligrams per pound of body weight. Administer once intramuscularly or subcutaneously.
For control of respiratory disease in cattle at high risk of developing bovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica.
13.6 milligrams per pound of body weight. Administer once intramuscularly or subcutaneously.
For treatment of pneumonia and shipping fever complex associated with Pasteurella species and Histophilus species, foot-rot and diphtheria caused by Fusobacterium necrophorum, bacterial enteritis (scours) caused by Escherichia coli, wooden tongue caused by Actinobacillus lignieresii, leptospirosis caused by Leptospira pomona, and wound infections and acute metritis caused by strains of staphylococcal and streptococcal organisms sensitive to oxytetracycline.
3 to 5 milligrams per pound of body weight per day. For treatment of severe foot-rot and advanced cases of other indicated diseases, 5 milligrams per pound of body weight per day. Administer intramuscularly, subcutaneously, or intravenously. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days.
For treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli, pneumonia caused by Pasteurella multocida, and leptospirosis caused by Leptospira pomona.
3 to 5 milligrams per pound of body weight per day. Administer intramuscularly. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days.
For treatment of pneumonia caused by Pasteurella multocida where retreatment for pneumonia is impractical.
9 milligrams per pound of body weight. Administer once intramuscularly.
As an aid in control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
3 milligrams per pound of body weight. Administer once intramuscularly approximately 8 hours before farrowing or immediately after completion of farrowing.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Treatment should be continued 24 to 48 hours following remission of disease symptoms, but not to exceed a total of 4 consecutive days. If no improvement occurs within 24 to 48 hours, reevaluate diagnosis and therapy. Discontinue use at least 19 days prior to slaughter. This drug product is not approved for use in female dairy cattle 20months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
If no improvement is noted within 24 to 48 hours, consult a veterinarian for diagnosis and therapy. In adult livestock, do not inject more than 10 milliliters at any one site. Rapid intravenous administration may result in animal collapse. Oxytetracycline should be administered intravenously slowly over a period of at least5 minutes.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For treatment of bacterial enteritis caused by Salmonella typhimurium and Escherichia coli (colibacillosis) and bacterial pneumonia (shipping fever complex, pasteurellosis) caused by Pasteurella multocida.
Orally administer 2 tablets per 100 lb of body weight every 12 hours (10 mg/lb of body weight daily in divided doses) for up to 4 consecutive days. Dosage should continue until the animal returns to normal and for 24-48 hours after symptoms have subsided. Treatment should not exceed 4 consecutive days.
For control of bacterial enteritis caused by Salmonella typhimurium and Escherichia coli (colibacillosis) and bacterial pneumonia (shipping fever complex, pasteurellosis) caused by Pasteurella multocida.
Orally administer 1 tablet per 100 lb of body weight every 12 hours (5 mg/lb of body weight daily in divided doses) for up to 4 consecutive days. Dosage should continue until the animal returns to normal and for 24-48 hours after symptoms have subsided. Treatment should not exceed 4 consecutive days.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Feed continuously for 5 days. Do not administer to chickens producing eggs for human consumption. Withdraw 24 hours before slaughter. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues.
Feed continuously for 7 to 14 days. Do not administer to chickens producing eggs for human consumption. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues.
Feed continuously for 7 to 14 days. Do not administer to chickens producing eggs for human consumption. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues.
Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter. Do not administer to turkeys producing eggs for human consumption.
Feed continuously for 7 to 14 days. Do not administer to turkeys producing eggs for human consumption.
Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter. Do not administer to turkeys producing eggs for human consumption.
Feed continuously for 7 to 14 days.
For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline.
Feed continuously for not more than 14 days.
For the reduction of the incidence of liver abscesses.
75 milligrams per head per day.
Feed continuously.
Treatment of bacterial enteritis caused by E. coli.
10 milligrams per pound of body weight daily.
Feed continuously for 7 to 14 days. In milk replacer or starter feed. Withdraw 0 days before slaughter. When used in milk replacers, the treatment claim (10 mg/lb) is limited to bacterial enteritis caused by E. coli only.
Treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline).
10 milligrams per pound of body weight daily.
Feed continuously for 7 to 14 days. Withdraw 0 days before slaughter.
Feed 3 to 5 days before and after arrival in feedlots.
For treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida susceptible to oxytetracycline.
10 milligrams per pound of body weight daily.
Feed continuously for 7 to 14 days. Withdraw 5 days before slaughter.
Administer as sole ration for 5 consecutive days. Withdraw medicated feed 30 days before harvesting lobsters.
Control of American Foulbrood caused by Bacillus larvae, and European foulbrood caused by Streptococcus pluton susceptible to oxytetracycline.
200 milligrams per colony.
Remove at least 6 weeks prior to main honey flow.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline and increased rate of weight gain and improved feed efficiency.
10 to 25 grams carbadox and approximately 400 grams of chlortetracycline (varying with body weight and feed consumption to provide 10 milligrams of chlortetracycline per pound of body weight daily).
Feed continuously as the sole ration for 7 to 14 days. Not for use in pregnant swine or swine intended for breeding purposes. Do not mix in feeds containing bentonite. Do not feed to swine within 42 days of slaughter.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Control of chronic respiratory disease (CRD) and air sac infections caused by Mycoplasma gallisepticum and E. coli susceptible to oxytetracycline; control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
200 to 400 milligrams per gallon of drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Withdraw 5 days prior to slaughter.
Control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline.
200 - 400 milligrams per gallon of drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Withdraw 5 days prior to slaughter.
25 milligrams per pound of body weight.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Withdraw 5 days prior to slaughter.
Control and treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero-day slaughter withdrawal in swine.
Control and treatment of leptospirosis (reducing the incidence of abortions and shedding of leptospira) caused by Leptospira pomona susceptible to oxytetracycline.
10 milligrams per pound of body weight.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero–day slaughter withdrawal in swine.
Control and treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as sole source of oxytetracycline. Do not administer this product with milk or milk replacers. Administer 1 hour before or 2 hours after feeding milk or milk replacers. Withdraw 5 days prior to slaughter. A milk discard period has not been established for this product in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older.
Control and treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Withdraw 5 days prior to slaughter.
Control of American foul brood caused by Paenibacillus larvae susceptible to oxytetracycline.
200 milligrams per colony, administered via either an 1:1 sugar syrup (equal parts of sugar and water weight to weight) or dusting with a powdered sugar mixture.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. The drug is administered in 3 applications of sugar syrup or 3 dustings at 4- to 5- days intervals. The drug should be fed early in the spring or fall and consumed by the bees before main honey flow begins to avoid contamination of production honey. Remove at least 6 weeks prior to main honey flow. Dusting of uncapped brood cells has been reported to cause death of larval honey bees. Do not dust uncapped brood cells.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control of chronic respiratory disease (CRD) and air sac infections caused by Mycoplasma gallisepticum and E. coli susceptible to oxytetracycline; control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
For the control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline.
200 – 400 milligrams per gallon of drinking water.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Withdraw 5 days before slaughter.
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Withdraw 5 days before slaughter.
Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Withdraw 5 days before slaughter.
Control and treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero-day slaughter withdrawal in swine.
Control and treatment of leptospirosis (reducing the incidence of abortions and shedding of leptospira) caused by Leptospira pomona susceptible to oxytetracycline.
10 milligrams per pound of body weight.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero–day slaughter withdrawal in swine.
Control and treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as sole source of oxytetracycline. Do not administer this product with milk or milk replacers. Administer 1 hour before or 2 hours after feeding milk or milk replacers. Withdraw 5 days prior to slaughter. A milk discard period has not been established for this product in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older.
Control and treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by P. multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Withdraw 5 days prior to slaughter.
Control of American foul brood caused by Paenibacillus larvae susceptible to oxytetracycline.
200 milligrams per colony, administered via either a 1:1 sugar syrup (equal parts of sugar and water weight to weight) or dusting with a powdered sugar mixture.
Immerse fish in a solution containing 200 to 700 mg oxytetracycline hydrochloride (buffered) per liter of water for 2 to 6 hours.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For chickens as an aid in the reduction of mortality due to air-sacculitis (air-sac infection) caused by Escherichia coli sensitive to oxytetracycline and for the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti E. mivati, and E. maxima.
500 grams oxytetracycline and 40 to 60 grams salinomycin sodium per ton of feed of Type C medicated feed.
Feed for 5 days as sole ration. Treat at first clinical signs of disease. Do not feed to laying chickens. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Withdraw 24 hours before to slaughter. Do not use in feeds containing pellet binders. May be fatal if accidentally fed to adult turkeys or to horses.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For chickens for control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to oxytetracycline, and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, Eimeria tenella, Eimeria acervulina, Eirmeria brunetti, Eimeria mivati, and Eimeria maxima.
30 grams robenidine hydrochloride and 400 grams oxytetracycline per ton of Type C medicated feed.
Feed continuously for 7 to 14 days. Do not feed to chickens producing eggs for human consumption. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Withdraw 5 days before slaughter. Feed must be used within 50 days from date of manufacture. Do not use in feeds containing bentonite.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
As an aid in the reduction of mortality due to air-sacculitis (air-sac infection) caused by Escherichia coli sensitive to oxytetracycline; for the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti E. mivati, and E. maxima.
500 grams oxytetracycline and 40 to 60 grams salinomycin sodium per ton of feed of Type C medicated feed.
Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Feed for 5 days as sole ration. Treat at first clinical signs of disease. Do not feed to laying chickens. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Withdraw 24 hours prior to slaughter. Do not use in feeds containing pellet binders. May be fatal if accidentally fed to adult turkeys or to horses.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Immerse fish in a solution containing 200 to 700 mgoxytetracycline hydrochloride (buffered) per liter of water for 2 to 6 hours.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
Administer 200 to 400 milligrams of powder per gallon of drinking water.
Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Use as the sole source of oxytetracycline. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
For the control of chronic respiratory disease (CRD) and air sac infections caused by Mycoplasma gallisepticum and E. coli susceptible to oxytetracycline; for the control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline.
Administer 400 to 800 milligrams of powder per gallon of drinking water.
Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Use as the sole source of oxytetracycline. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
For the control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline.
Administer 200 to 400 milligrams of powder per gallon of drinking water.
Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Use as the sole source of oxytetracycline. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
For the control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
Administer 400 milligrams of powder per gallon of drinking water.
Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Use as the sole source of oxytetracycline. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
For the control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to oxytetracycline.
Administer 25 milligrams per pound of body weight in drinking water.
Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Use as the sole source of oxytetracycline. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
For the control and treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
Administer 10 milligrams per pound of body weight daily in drinking water.
Prepare a fresh solution daily. Use as the sole source of oxytetracycline. Administer up to 5 days; do not use for more than 5 consecutive days. Use as sole source of drinking water. Do not mix this product directly with milk or milk replacers. Administer one hour before or two hours after feeding milk or milk replacers. Withdraw zero days prior to slaughter. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
For the control and treatment of leptospirosis (reducing the incidence of abortions and shedding of leptospira) caused by Leptospira pomona susceptible to oxytetracycline.
Administer 10 milligrams per pound of body weight daily in drinking water.
Prepare a fresh solution daily. Use as the sole source of oxytetracycline. Administer up to 5 days; do not use for more than 5 consecutive days. Use as sole source of drinking water. Do not mix this product directly with milk or milk replacers. Administer one hour before or two hours after feeding milk or milk replacers. Withdraw zero days prior to slaughter. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Control of chronic respiratory disease (CRD) and air sac infections caused by Mycoplasma gallisepticum and E. coli and fowl cholera caused by Pasteurella multocida.
400 to 800 milligrams per gallon of drinking water.
Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
200 to 400 milligrams per gallon of drinking water.
Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
200 to 400 milligrams per gallon of drinking water.
Administer for 7 to 14 days; do not slaughter for food within 4 days of treatment; not for use in turkeys producing eggs for human consumption; prepare a fresh solution daily; use as the sole source of tetracycline.
400 milligrams per gallon of drinking water.
Administer for 7 to 14 days; do not slaughter for food within 4 days of treatment; not for use in turkeys producing eggs for human consumption; prepare a fresh solution daily; use as the sole source of tetracycline.
Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis).
25 mg/lb of body weight per day in drinking water.
Administer for 7 to 14 days; do not slaughter for food within 4 days of treatment; not for use in turkeys producing eggs for human consumption; prepare a fresh solution daily; use as the sole source of tetracycline.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption.
Control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Zero day slaughter withdrawal in turkeys.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Zero day slaughter withdrawal in turkeys.
25 milligrams per pound of body weight.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of oxytetracycline. Use as a sole source of drinking water. Do not use in birds producing eggs for human consumption. Zero day slaughter withdrawal in turkeys.
Control and treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Administer up to 5 days. Do not use for more than 5 consecutive days. Zero day slaughter withdrawal in swine.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 5 days. Do not use for more than 5 consecutive days. Use as sole source of oxytetracycline. Do not administer this product with milk or milk replacers. Administer 1 hour before or 2 hours after feeding milk or milk replacers. Withdraw 5 days prior to slaughter. A milk discard period has not been established for this product in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older.
Control and treatment of leptospirosis (reducing the incidence of abortions and shedding of leptospira) caused by Leptospira pomona susceptible to oxytetracycline.
10 milligrams per pound of body weight.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Administer up to 5 days. Do not use for more than 5 consecutive days. Zero day slaughter withdrawal in swine.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer up to 5 days. Do not use for more than 5 consecutive days. Use as a sole source of oxytetracycline. Withdraw 5 days prior to slaughter.
Control of American foul brood caused by Paenibacillus larvae susceptible to oxytetracycline.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. The drug is administered in 3 applications of sugar syrup or 3 dustings at 4- to 5- days intervals. The drug should be fed early in the spring or fall and consumed by the bees before main honey flow begins to avoid contamination of production honey. Remove at least 6 weeks prior to main honey flow. Dusting of uncapped brood cells has been reported to cause death of larval honey bees. Do not dust uncapped brood cells.
For skeletal marking of finfish fry and fingerlings.
Immerse fish in a solution containing 200 to 700 mg oxytetracycline hydrochloride (buffered) per liter of water for 2 to 6 hours.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian. For skeletal marking of finfish fry and fingerlings.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
- Coban™/TM® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Neo-Oxy 50/50® (ZIP)
- Neo-Oxy 100/100 MR® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Neo-Terramycin® 100/100 (ZIP)
- Neo-Terramycin® 50/50D (ZIP)
- Neo-Terramycin® 50/50 (ZIP)
- Neo-Terramycin® 100/100D (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For improved feed efficiency, increased rate of weight gain and reduction of the incidence and severity of liver abscesses in beef cattle fed in confinement for slaughter.
- BOVATEC® and TM® (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
Summary
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat) and reduction of liver condemnation due to liver abscesses in heifers being fed in confinement for slaughter.
- MGA® and TM® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat) and reduction of liver condemnation due to liver abscesses in heifers being fed in confinement for slaughter.
- MGA® (liquid) and TM® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for the establishment of a tolerance of 750 parts per billion (ppb) for the sum of tetracycline residues in honey.
-
FOI ucm049519.pdf
Summary
To provide a new indication for the marking of skeletal tissues in finfish fry and fingerlings. -
FOI ucm049517.pdf
Summary
This supplement establishes a zero-day withdrawal period for swine administered oxytetracycline at 10 mg/lb/day for 14 days. -
FOI UCM523939.pdf
Summary
One supplemental application is a Category II change to bring the drug product into compliance with the National Academy of Science/National Research Council Drug Efficacy Study Implementation (NAS/NRC/DESI) recommendations. The other supplemental application is a Category II change providing for a tolerance of O.1 ppm in uncooked edible tissues in sheep.
- TERRAMYCIN-343® (ZIP)
- TERRAMYCIN® (ZIP)
- TERRAMYCIN® Soluble Powder Concentrate (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm079545.pdf
Summary
This supplement establishes a zero-day preslaughter withdrawal period for cattle administered oxytetracycline at 10 mg/lb/day for 14 days.
-
FOI ucm079541.pdf
Summary
This supplement establishes a zero-day withdrawal period for swine administered oxytetracycline at 10 mg/lb/day for 14 days -
Summary
For the control and treatment of specific diseases susceptible to oxytetracycline dihyrate pre-mix in swine, calves, cattle, chickens, turkeys, sheep, and honey bees.
- Terramycin® 10 (ZIP)
- Terramycin® 30 (ZIP)
- Terramycin® 50 (ZIP)
- Terramycin® 100 (ZIP)
- Terramycin® 200 (ZIP)
- Terramycin® 200 Granular (ZIP)
- Terramycin® 100MR (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
Cattle: For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Haemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
Swine: For the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona. In sows, OxyMedâ¿¢ LA is indicated as an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
- Tetroxy®-LA (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Terramycin® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides information to address the human food safety and user safety of N-methyl-2-pyrrolidone (NMP) in the formulation of Oxytetracycline Injection, and provides for alignment with Guidance for Industry (GFI) #263, "Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntarily Bring Under Veterinary Oversight All Products That Continue to be Available Over-the-Counter."
-
Summary
Oxyshot™ LA is intended for use in the treatment of the following diseases in beef cattle, nonlactating dairy cattle and swine when due to oxytetracycline susceptible organisms.
Cattle: Oxyshot™ LA is indicated in the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Hemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
Swine: In swine, Oxyshot™ LA is indicated in the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona. In sows, Oxyshot™ LA is indicated as an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm054894.pdf
Summary
For the control and treatment of the following diseases of beef and dairy calves caused by organisms sensitive to oxytetracycline; bacterial entertis caused by Salmonella typhimurium and Escherichia coli (colibacillosis); bacterial pneumonia (shipping fever complex, pasteurellosis) caused by Pasteurella multocida.
- OXY 500 Calf Bolus (ZIP)
- OXY 1000 Calf Bolus (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061595.pdf
Summary
Beef cattle, dairy cattle, calves, including preruminating (veal) calves: indicated in the treatment of pneumonia and shipping fever complications associated with Pasteurella spp., and Hemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresi; leptospirosis caused by Leptospira pomona; and wound infection and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
Swine: indicated in the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona. In sows, it is indicated as an aid in the control of
infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by
Escherichia coli.
- AGRIMYCIN® 200 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm069807.pdf
Summary
This supplement provides for changes to the product labeling to include lactating dairy cows. Also, a tolerance for oxytetracycline in milk is established at 0.3ppm. -
Summary
This supplement provides for changes to the product labeling to include a subcutaneous (SC) route of administration in cattle. Also, the indications section of the labeling will be revised to include "pre-ruminating (veal) calves."
-
Summary
This supplement provides for the codification of a revised tolerance for residues of oxytetracycline in edible tissues.
-
EA 113-232
-
FONSI 113-232
- Liquamycin® LA-200® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061758.pdf
Summary
Cattle: For the treatment of pneumonia and shipping fever complex.
Swine: For the treatment of the bacterial enteritis.
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061589.pdf
Summary
The supplement provides for use in lactating dairy cattle. -
FOI ucm061587.pdf
Summary
Addition of subcutaneous route of administration for beef cattle, nonlactating dairy cattle, and preruminating (veal) calves. -
Summary
For use in the treatment of bacterial diseases in beef cattle, nonlactating dairy cattle and swine when caused by two oxytetracycline susceptible organisms.
- MAXIM-200 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061605.pdf
Summary
The supplement provides for the use in lactating diary cattle. -
FOI ucm061603.pdf
Summary
The supplement provides for the addition of the subcutaneous administration of oxytetracycline injectable solution in beef cattle, non-lactating dairy cattle, and calves, including pre-ruminating (veal) calves. -
Summary
For use in the treatment of infectious diseases in beef cattle, nonlactating dairy cattle and swine when due to oxytetracycline susceptible organisms.
- Pennox® 200 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
OXYTETRACYCLINE HCL INJECTABLE SOLUTION is for treatment of:
Pasteurella spp. -- Bacterial pneumonia and shipping fever complex associated with Pasteurella spp.
Escherichia coli -- Bacterial enteritis (scours)
Spherophorous necrophorus -- Necrotic pododermatitis (foot rot), calf diphtheria
Actinobacillus lignierseii -- Wooden tongue
Wound infection, acute metritis, traumatic injury -- caused by oxytetracycline susceptible strains of streptococcal and staphylococcal bacteria
- MAXIM 100 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061564.pdf
Summary
This supplemental application provides for the use in lactating cattle. -
FOI ucm061563.pdf
Summary
This supplemental application establishes a 28 day withdrawal period for subcutaneous use in cattle and intramuscular use in swine (all approved routes of administration in cattle and swine). -
FOI UCM351251.pdf
Summary
To add the subcutaneous route of administration to the label for cattle. -
FOI UCM351250.pdf
Summary
OXY-TET 200/BIO-MYCIN 200 is intended for use in the treatment of the following diseases in beef cattle, nonlactating dairy cattle and swine when due to oxytetracycline susceptible organisms. CATTLE: OXY-TET 200 is indicated in the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Hemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis ; foot rot and diphtheria caused by Fusobacterium necrophorum ; bacterial enteritis (scours) caused by Escherichia coli ; wooden tongue caused by Actinobacillus lignieresi ; leptospirosis caused by Leptospira pomona ; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline. SWINE: In swine, OXY-TET 200 is indicated in the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli ; pneumonia caused by Pasteurella multocida ; and leptospirosis caused by Leptospira pomona . In sows, OXY-TET 200 is indicated as an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
- Bio-Mycin® 200 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061378.pdf
Summary
The use of OXYTET 10 Injection is indicated in beef cattle, beef calves, non-lactating dairy cattle and dairy calves for the treatment of the following disease conditions caused by one or more of the oxytetracycline sensitive pathogens listed as follows Bacterial Pneumonia and Shipping Fever Complex associated with Pasteurella spp.; Bacterial Enteritis (scours) caused by Escherichia coli; Necrotic Pododermatitis (Foot Rot) and Calf Diphtheria caused by Fusobacterium necrophorum; Wooden Tongue caused by Actinobacillus lignieresii; and Wound Infections, Acute Metritis and Traumatic Injury caused by susceptible strains of streptococcusand staphylococcus organisms.
- Oxytet 100 (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Oxy-Tet™ Injection (ZIP)
- Bio-Mycin C (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Medamycin® 100 (ZIP)
- MEDAMYCIN® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Oxyject® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM468906.pdf
Summary
This supplemental NADA provides for the subcutaneous route of administration and the application of new tolerances (61 FR 67435) to the approved product, Oxyject® 100
- OXYJECT® 100 (ZIP)
- Status™ SQ (ZIP)
FDA page: Open in Animal Drugs @ FDA
- OXY-TET 50™ (ZIP)
- Bio-Mycin® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for the addition of an indication for the control of mortality due to columnaris disease associated with Flavobacterium columnare in catfish and freshwater-reared salmonids.
-
Summary
Freshwater-reared salmonids weighing up to 55 grams: For marking the skeletal tissue.
-
Summary
This supplement provides for the addition of an indication for the control of mortality in freshwater-reared salmonids due to coldwater disease associated with Flavobacterium psychrophilum, the addition of an indication for the control of mortality in freshwater-reared Oncorhynchus mykiss due to columnaris associated with Flavobacterium columnare, removal of the limitation on treating salmonids in water temperatures below 9°C, and the addition to the label of the previously approved indication for marking of skeletal tissue in Pacific salmon.
-
FOI ucm049542.pdf
Summary
This supplement provides for the change of the active ingredient from the mono-alkyl (C8-C18) trimethylammonium oxytetracycline to the oxytetracycline dihydrate, the change of the oxytetracycline concentration from 100 g/lb to 200 g/lb, the change of the product name to reflect the change in the oxytetracycline concentration, and the addition of the approved lobster indication to the label for the control of gaffkemia caused by Aerococcus viridans. -
EA 038-439
-
FONSI 038-439
-
EA 038-439
-
FONSI 038-439
- Terramycin® 100 for Fish (ZIP)
- Terramycin® 200 for Fish (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061599.pdf
Summary
FOR THE CONTROL AND TREATMENT OF THE FOLLOWING DISEASES IN SWINE – Bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis, and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline. FOR BREEDING SWINE: Leptospirosis (reducing the incidence of abortions and shedding of leptospira) caused by Leptospira pomona, susceptible to oxytetracycline.
-
Summary
- for control of Mycoplasma synoviae, M. gallisepticum, Escherichia coli, and Pasteurella multocida in chickens.
- for control of Hexamita meleagridis, Mycoplasma synoviae, transmissible eneritis and coronaviral enteritis in turkeys.
- for control and treatment of Escherichia coli, Salmonella choleraesuis, Pasteurella multiocida and Leptospira pomona in swine.
- Tetroxy® HCA-280 (ZIP)
- Tetroxy® HCA-1772 (ZIP)
- Tetroxy® HCA-1400 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm117183.pdf
Summary
Beef and non-lactating dairy cattle, calves, including pre-ruminating (veal) calves: for the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Haemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot-rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresi; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococcal and streptococcal organisms sensitive to oxytetracycline. Also, TETRADURE 300 is indicated (prescription use) for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia (Pasteurella) haemolytica. Swine: for the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona. In sows, oxytetracycline is indicated as an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
- Noromycin® 300 LA (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
Oxytetracycline HCl (50 mg and 100 mg) is intended for use in the treatment of the following diseases in beef cattle and non-lactating dairy cattle when due to oxytetracycline-susceptible organisms:
Cattle: In cattle, Oxytetracycline (50 mg and 100 mg) is indicated in the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Hemophilus spp.; foot-rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.
If the product contains the statement "Federal law restricts this drug to use by or on the order of a licensed veterinarian," it may contain additional directions for use in beef cattle and non-lactating dairy cattle for the treatment of anaplasmosis caused by Anaplasma marginale and anthrax caused by Bacillus anthracis.
- Biocyl-50 (ZIP)
- Biocyl-100 (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Oxytetracycline-50 (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Oxyvet-100 (ZIP)
- Aquachel-100 (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Terramycin® 100 (ZIP)
- Liquamycin® 100 (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM243040.pdf
Summary
For the treatment of bacterial pneumonia associated with Pasteurella spp. and for the control of associated pyrexia in beef and non-lactating dairy cattle.
- Hexasol® Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm049522.pdf
Summary
For increased rate of weight gain and improved feed efficiency; reduction of liver abscesses; for prevention and treatment of the early stages of shipping fever complex; the treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline.
-
FOI ucm049521.pdf
Summary
This supplement establishes a zero-day withdrawal period for swine administered oxytetracycline at 10 mg/lb/day for 14 days. -
Summary
This supplement establishes a zero-day withdrawal period for swine administered oxytetracycline at 10 mg/lb/day for 14 days.
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm118005.pdf
Summary
For the treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline, treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline, and increased rate of weight gain and improved feed efficiency.
- Mecadox® and Terramycin® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM283519.pdf
Summary
To add a claim for the marking of skeletal marking of tissues of all finfish fry and fingerlings. -
FOI ucm069857.pdf
Summary
This supplement provides for a revised withdrawal time of oxytetracycline hydrochloride soluble powder in the drinking water of turkeys and swine. -
Summary
This supplement provides for use of this product in swine.
-
EA 130-435
-
FONSI 130-435
- Oxytet® Soluble (ZIP)
- OXYMarine™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM436419.pdf
Summary
This supplement provides for a change in the proprietary name from Oxytetracycline HCl Soluble Powder to Tetroxy 25®, the removal of the residue warning statement for pre-ruminating and veal calves from the labeling and the addition of a new species (honey bees) and the corresponding indications. Tetroxy 25® is indicated for the control of American Foulbrood caused by Paenibacillus larvae and European Foulbrood caused by Streptococcus pluton susceptible to oxytetracycline. -
Summary
This supplemental application provides for the addition of the 2.26 kg (5 lb) bucket with a scoop. The scoop has also been added to the 907.2 g (2 lb) bucket. Revised labeling provides the statement warning against use in calves to be processed for veal and female dairy cattle 20 months of age or older.
-
Summary
For control control and treatment of a variety of infectious diseases caused by bacteria susceptible to oxytetracycline in chickens turkeys swine, cattle, and sheep.
- Tetroxy® 25 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061679.pdf
Summary
This supplemental applicaiton provides for the additional use in a new species, finfish fry and fingerlings, for skeletal marking by immersion as an aid in identification. -
FOI ucm061678.pdf
Summary
OXYTETRACYCLINE HCL SOLUBLE POWDER – 343 is indicated for a variety of bacterial infections in cattle, sheep, swine, chickens, turkeys, and honeybees associated with organisms susceptible to oxytetracycline. CALVES, BEEF CATTLE AND NON-LACTATING DAIRY CATTLE: Control and treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida.
SHEEP: Control and treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida.
SWINE: Control and treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida. For Breeding Swine: Leptospirosis (reducing the incidence of abortions and shedding of leptospira) caused by Leptospira pomona.
CHICKENS: Control of infectious synovitis caused by Mycoplasma synoviae, chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli, and fowl cholera caused by Pasteurella multocida.
TURKEYS: Control of hexamitiasis caused by Hexamita meleagridis and infectious synovitis caused by Mycoplasma synoviae. Growing turkeys-complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis).
HONEYBEES: Control and treatment of American and European foulbrood caused by Bacillus larvae. -
FOI ucm061676.pdf
Summary
Chickens: For the control and treatment of infectious synovitis caused by Mycoplasma synoviae; chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli; fowl cholera caused by Pasteurella multocida. Turkeys: For the control and treatment of hexamitiasis caused by Hexamita meleagridis; infectious synovitis caused by Mycoplasma synoviae; and control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis).
Cattle: For the treatment and control in calves, beef cattle and nonlactating dairy cattle of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida.
Swine: For the control and treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis, bacterial pneumonia caused by Pasteurella multocida; and reducing the incidence of abortions and shedding of leptospira in breeding swine caused by Leptospira pomona.
Sheep: For the treatment and control of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida.
- Tetroxy® 343 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM478012.pdf
Summary
As an aid in the reduction of mortality due to air sacculitis (air sac infection) caused by Escherichia coli sensitive to oxytetracycline and for the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati and E. maxima .
- TM® plus Bio-Cox® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- TM® plus Robenz® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the prevention of coccidiosis in broiler chickens caused by Eimeria tenella, E. necatrix, E. acervulina, E. maxima, E. brunetti , and E. mivati , and as an aid in the reduction of mortality due to airsacculitis (air sac infection) caused by Escherichia coli infections sensitive to oxytetracycline.
- Sacox® / Terramycin® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061380.pdf
Summary
To mark skeletal tissues, most often the otoliths, of all finfish fry and fingerlings for subsequent identification.
- Tetroxy® Aquatic (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061580.pdf
Summary
The supplement provides for approval of an additional packet size, 9.87 oz [280 g], a different trade name, an alternate concentration of active ingredient and a change in the inactive ingredients in the finished dosage form. -
FOI ucm061578.pdf
Summary
Revised withdrawal period for turkeys and swine.Under the provisions of the Federal Food, Drug, and Cosmetic Act, as amended by the Generic Animal Drug and Patent Term Restoration Act, (53 FR 50460, December 15, 1988, First GADPTRA Policy Letter) an abbreviated new animal drug application (ANADA) may be submitted for a generic version of an approved new animal drug (pioneer product). New target animal safety data, drug effectiveness data, and human food safety data (other than tissue residue data) are not required for approval of an ANADA. An ANADA relies on the target animal safety, drug effectiveness, and human food safety data in the pioneer's new animal drug application. Ordinarily, the ANADA sponsor shows that the generic product is bioequivalent to the pioneer. If bioequivalence is demonstrated through a clinical end-point study, then a tissue residue study to establish the withdrawal time for the generic product is also required. For certain dosage forms, the agency will grant a waiver from conducting an in vivo bioequivalence study (55 FR 24645, June 18, 1990; Fifth GADPTRA Policy Letter; Bioequivalence Guideline, April 1990).Based upon the formulation characteristics of the genetic product, Agri Laboratories Ltd. was granted a waiver from conducting an in vivo bioequivalence study for Oxytetracycline HCl Soluble Powder. The genetic and pioneer products contain the same active ingredient and are water soluble powders administered as oral solutions. The genetic product contains no inactive ingredients that may significantly affect the absorption of the active ingredient. -
Summary
CHICKENS
Control of infectious synovitis caused by Mycoplasma synoviae
Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli
Control of fowl cholera caused by Pasteurella multocida
TURKEYS
Control of Hexamitiasis caused by Hexamita meleagridis
Control of infectious synovitis caused by Mycoplasma synoviae
Growing turkeys: Control of body weight complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis)
SWINE
FOR THE CONTROL AND TREATMENT OF THE FOLLOWING DISEASES IN SWINE:
Bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis, susceptible to oxytetracycline. Bacterial pneumonia caused by Pasteurella multocida, susceptible to oxytetracycline.
FOR BREEDING SWINE: Leptospirosis (reducing the incidence of abortions and shedding of leptospira) caused by Leptospira pomona, susceptible to oxytetracycline.
- AGRIMYCIN®-343 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
The effectiveness oxytetracycline HCl soluble powder was reviewed by the National Academy of Sciences/National Research Council Drug Efficacy Study Implementation (NAS/NRC DESI) and has been deemed effective when labeled as specified in the Indications and Recommended Dosage section of the summary.
- OXY WS™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM252253.pdf
Summary
This supplement provides for the addition of new species (finfish and honey bees) and their corresponding indications to all labeling components. -
FOI ucm061570.pdf
Summary
Revised withdrawal period (0-day) in swine -
FOI ucm061566.pdf
Summary
Revised withdrawal period (0-day) in turkeys & additional package size of 23.9 oz.. -
FOI ucm061565.pdf
Summary
Control of certain diseases caused by bacteria susceptible to oxytetracycline hydrochloride.
- Pennox 343® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Aquachel 100 mg (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM061648.pdf
Summary
The supplement provides for the addition of the subcutaneous administration of oxytetracycline injectable solution in cattle and for the use in lactating dairy cattle. -
FOI UCM061645.pdf
Summary
Cattle: For the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Hemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infection and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline. Swine: For the treatment of the bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona. In sows as an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
- Geomycin 200 (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Liquamycin® Injectable (ZIP)
- Terramycin® Injectable (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061757.pdf
Summary
For the treatment of bacterial diseases in chickens, turkeys, and swine.
FDA page: Open in Animal Drugs @ FDA
- Oxytetracycline Premix (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Terra-Cortril Spray (ZIP)
- Liqua-Cortril Spray (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Terramycin® Egg Formula (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Terramycin® Premix (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Terramycin® Vet Capsules (ZIP)
FDA page: Open in Animal Drugs @ FDA
- TM®-10 Premix (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Usage
It is used in dogs for the treatment of bacterial pneumonia caused by Brucella bronchiseptica, tonsillitis caused by Streptococcus hemolyticus, bacterial enteritis caused by Escherichia coli, urinary tract infections caused by Escherichia coli, and wound infections caused by Staphylococcus aureus. The drug can be used for continuation of compatible antibiotic therapy following parenteral oxytetracycline administration where rapidly attained, sustained antibiotic blood levels are required. The duration of treatment required to obtain favorable response will depend to some extent on the severity and degree of involvement and the susceptibility of the infectious agent. Clinical response to antibiotic therapy usually occurs within 48 to 72 hours. If improvement is not observed within that period, the diagnosis and course of treatment should be reconsidered. To assure adequate treatment, administration of the drug should continue for at least 48 hours following favorable clinical response. It is used in cats for the treatment of bacterial pneumonia caused by Brucella bronchiseptica, tonsillitis caused by Streptococcus hemolyticus, bacterial enteritis caused by Escherichia coli, urinary tract infections caused by Escherichia coli, and wound infections caused by Staphylococcus aureus. The drug can be used for continuation of compatible antibiotic therapy following parenteral oxytetracycline administration where rapidly attained, sustained antibiotic blood levels are required. The duration of treatment required to obtain favorable response will depend to some extent on the severity and degree of involvement and the susceptibility of the infectious agent. Clinical response to antibiotic therapy usually occurs within 48 to 72 hours. If improvement is not observed within that period, the diagnosis and course of treatment should be reconsidered. To assure adequate treatment, administration of the drug should continue for at least 48 hours following favorable clinical response. Control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Prepare a fresh solution daily. Administer 7 to 14 days. Not to be used for more than 14 consecutive days. Use as sole source of drinking water. Do not use in birds producing eggs for human consumption. Prepare a fresh solution daily. Administer up to 14 days. Do not use for more than 14 consecutive days. Use as a sole source of oxytetracycline. Zero-day slaughter withdrawal in swine.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 8 and Cat 8 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Domestic Shorthair, Male, 8 year, 5.44 kilogram • Drug: MSK, Unknown • Reactions: Behavioral disorder (unspecified), Tiredness (lethargy), Vomiting, Decreased appetite, Death by euthanasia • Outcome: Euthanized
- Report ID: USA-USFDACVM-2024-US-070360
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 8.00 Year
- Weight: 5.440 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, Siamese, Female, 1 year, 3.26 kilogram • Drug: MSK, Unknown • Reactions: Behavioral disorder (unspecified), Unsteady walking (ataxia), Weight loss, Walking difficulty, Third eyelid extrusion • Outcome: Ongoing
- Report ID: USA-USFDACVM-2024-US-043413
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 1.00 Year
- Weight: 3.260 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, Domestic Shorthair, Unknown, 10.5 year, 5.3 kilogram • Drug: MSK, Unknown • Reactions: Not urinating, Urinary bladder disorder NOS • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2024-US-041896
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Unknown
- Age: 10.50 Year
- Weight: 5.300 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, Cat (other), Female, 11 year, 3.62 kilogram • Drug: MSK, Unknown • Reactions: Constipation, Decreased bowel movements, Death by euthanasia • Outcome: Euthanized
- Report ID: USA-USFDACVM-2024-US-004991
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 11.00 Year
- Weight: 3.620 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, Schnauzer - Miniature, Female, 9 month, 6.07 kilogram • Drug: MSK, Parenteral • Reactions: Leucocytosis NOS, Neutrophilia, Injection site pain, Shaking, Licking… • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2023-US-040406
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 9.00 Month
- Weight: 6.070 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Parenteral
Cat, Domestic Shorthair, Male, 2 year, 6.9 kilogram • Drug: MSK, Ointment, Unknown • Reactions: Dilated pupils, Abnormal pupil light reflex, Unsteady gait, Head shake - ear disorder, Head tilt - neurological disorder… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2023-US-021175
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 2.00 Year
- Weight: 6.900 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Ointment
Dog, Chihuahua, Male, 14 year, 4.649 kilogram • Drug: MSK, Unknown • Reactions: Partial deafness, Nasal discharge • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2020-US-027496
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 14.00 Year
- Weight: 4.649 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, Bulldog, Male, 39.009 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Corneal ulcer, Hives, Skin inflammation NOS • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2016-US-013744
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Weight: 39.009 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.